Choose Your News
Loading...
Thumbnail
Applied Therapeutics is a clinical-stage biopharmaceutical company, developing product candidates against molecular targets for indications of different illness... [Read More]
Thumbnail
Applied Therapeutics has filed to raise $86 million in a U.S. IPO. The firm is advancing a pipeline of treatments for cardiomyopathy and other conditions... [Read More]
Preview